Advisor Group Holdings, Inc. Sab Biotherapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.62 - $1.0 $186 - $300	-300 Reduced 0.64%	46,373 $31,000
Q3 2023 Nov 13, 2023	BUY	$0.47 - $0.9 $13,055 - $24,999	27,777 Added 147.0%	46,673 $29,000
Q2 2023 Aug 10, 2023	SELL	$0.38 - $1.09 $76 - $218	-200 Reduced 1.05%	18,896 $15,000
Q4 2022 Feb 10, 2023	BUY	$0.54 - $9.8 $9,116 - $165,453	16,883 Added 762.9%	19,096 $11,000
Q2 2022 Aug 10, 2022	BUY	$1.11 - $3.46 $980 - $3,055	883 Added 66.39%	2,213 $3,000
Q1 2022 May 04, 2022	BUY	$1.78 - $8.5 $2,367 - $11,305	1,330 New	1,330 $5,000

529K

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $133M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.